Cited by 351Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerFOXO transcription factor regulation

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy

Open access

Mayo, Lindsey D., Dixon, Jack E., Durden, Donald L., Tonks, Nickolas K., Donner, David B.·2002·Journal of Biological Chemistry

DOI 10.1074/jbc.m108302200

Open this paper in CoChat — free account

Abstract

The PTEN tumor suppressor protein inhibits phosphatidylinositol 3-kinase (PI3K)/Akt signaling that promotes translocation of Mdm2 into the nucleus. When restricted to the cytoplasm, Mdm2 is degraded. The ability of PTEN to inhibit the nuclear entry of Mdm2 increases the cellular content and transactivation of the p53 tumor suppressor protein. Retroviral transduction of PTEN into U87MG (PTEN null) glioblastoma cells increases p53 activity and expression of p53 target genes and induces cell cycle arrest. U87MG/PTEN glioblastoma cells are more sensitive than U87MG/PTEN null cells to death induced by etoposide, a chemotherapeutic agent that induces DNA damage. Previously, tumor suppressor proteins have been supposed to act individually to suppress cancers. Our results establish a direct connection between the activities of two major tumor suppressors and show that they act together to respond to stresses and malignancies. PTEN protects p53 from survival signals, permitting p53 to function as a guardian of the genome. By virtue of its capacity to protect p53, PTEN can sensitize tumor cells to chemotherapy that relies on p53 activity. p53 induces PTEN gene expression, and here it is shown that PTEN protects p53, indicating that a positive feedback loop may amplify the cellular response to stress, damage, and cancer.

Integrity signals

Registry

Crossref · 10.1074/jbc.m108302200

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

Flagged first, then by citations

Show all 64 references

Research works printed but not linked: 8

Furnari, 1998, Cancer Res., 58, 5002
Chen, 1993, Mol. Cell. Biol., 13, 4107
Kubbutat, 1999, Cell Growth Diff., 10, 87
Greenblatt, 1994, Cancer Res., 54, 4855
Finlay, 1993, Mol. Cell. Biol., 13, 301
Cheney, 1998, Cancer Res., 58, 2331
Reifenberger, 1993, Cancer Res., 53, 2736
Kondo, 1995, Oncogene, 10, 2001

Sorted by citations

Items 101–200 of 351

Respiratory Syncytial Virus Decreases p53 Protein to Prolong Survival of Airway Epithelial Cells
Groskreutz, D. J., Monick, M. M., Yarovinsky, T. O., Powers, L. S., Quelle, D. E., Varga, S. M., Look, D. C., & Hunninghake, G. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2741 · Cited by 71
Pi3 Kinase/Akt Pathway As A Therapeutic Target In Multiple Myeloma
Harvey, R. D., & Lonial, S. (2007) · Future Oncology · doi:10.2217/14796694.3.6.639 · Cited by 72
Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
Gallo, G., Vescio, G., Paola, G. D., & Sammarco, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112295 · Cited by 72
Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53
Kim, H., Kwak, N., Lee, J., Choi, B. H., Lim, Y., Ko, Y. J., Kim, Y.-H., Huh, P., Lee, K.-H., Rha, H. K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305526200 · Cited by 71
Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression—transcriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway
Choi, H., Chung, T., Kang, S., Lee, Y., Ko, J., Kim, J.-G., & Kim, C. (2006) · Glycobiology · doi:10.1093/glycob/cwj105 · Cited by 71
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 72
In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin
Tanaka, M., & Grossman, H. B. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302056 · Cited by 70
Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway.
Jimenez, A. I., Fernández, P., Domı́nguez, O., Dopazo, A., & Sánchez‐Céspedes, M. (2003) · PubMed · Cited by 68
Upregulation of Circular RNA circATRNL1 to Sensitize Oral Squamous Cell Carcinoma to Irradiation
Chen, G., Li, Y., He, Y., Zeng, B., Chen, Y., Wang, C., Zhang, X., Zhao, W., & Yu, D. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.031 · Cited by 64
CXCL8 Signaling in the Tumor Microenvironment
Asokan, S., & Bandapalli, O. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_3 · Cited by 66
Clinical significance of tumor suppressor PTEN in colorectal carcinoma
Hsu, C.-P., Kao, T., Chang, W., Nieh, S., Wang, H. L., & Chung, Y. C. (2010) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2010.12.003 · Cited by 65
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
Olivos, D. J., & Mayo, L. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121982 · Cited by 67
Self-citation
PTEN: Its Deregulation and Tumorigenesis
Maehama, T. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1624 · Cited by 66
Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome
Pezzolesi, M. G., Zbuk, K. M., Waite, K. A., & Eng, C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm053 · Cited by 62
Mitochondrial Dysfunction Impairs Tumor Suppressor p53 Expression/Function
Compton, S. L., Kim, C. G., Griner, N. B., Potluri, P., Scheffler, I. E., Sen, S., Jerry, D. J., Schneider, S. S., & Yadava, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163063 · Cited by 62
Targeting the PI3K Pathway for Cancer Therapy
Sadeghi, N., & Gerber, D. E. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.56 · Cited by 59
Basic Science Review: Nitric Oxide—Releasing Prosthetic Materials
Varu, V. N., Tsihlis, N. D., & Kibbe, M. R. (2008) · Vascular and Endovascular Surgery · doi:10.1177/1538574408322752 · Cited by 59
Characterization of Dual PTEN and p53-Targeting MicroRNAs Identifies MicroRNA-638/Dnm2 as a Two-Hit Oncogenic Locus
Tay, Y., Tan, S. M., Karreth, F. A., Lieberman, J., & Pandolfi, P. P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.064 · Cited by 60
TSH overcomes BrafV600E-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer
Zou, M., Baitei, E. Y., Al‐Rijjal, R. A., Parhar, R. S., Al-Mohanna, F. A., Kimura, S., Pritchard, C. A., BinEssa, H. A., Alzahrani, A. S., Al‐Khalaf, H. H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.253 · Cited by 60
Antisense to the Early Growth Response‐1 Gene (Egr‐1) Inhibits Prostate Tumor Development in TRAMP Mice
Baron, V. T., Duss, S., Rhim, J. S., & Mercola, D. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1281.024 · Cited by 58
In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
Liu, H., Liang, Y., Wang, L., Tian, L., Song, R., Han, T., Pan, S., & Liu, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048075 · Cited by 57
Wild-Type p53 Protein Is Up-Regulated upon Cyclic Adenosine Monophosphate-Induced Differentiation of Human Endometrial Stromal Cells
Pohnke, Y., Schneider‐Merck, T., Fahnenstich, J., Kempf, R., Christian, M., Milde‐Langosch, K., Brosens, J. J., & Gellersen, B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0012 · Cited by 58
Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors
Ellert‐Miklaszewska, A., Ciechomska, I. A., & Kaminska, B. (2021) · Cancers · doi:10.3390/cancers13030419 · Cited by 56
Interference of Apoptosis by Hepatitis B Virus
Lin, S., & Zhang, Y. (2017) · Viruses · doi:10.3390/v9080230 · Cited by 58
Mechanisms That Enhance Sustainability of p53 Pulses
Kim, J. K., & Jackson, T. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065242 · Cited by 53
Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells
Han, T., Schoene, N. W., & Lei, K. Y. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00042.2009 · Cited by 53
Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes
Xie, Y., Naizabekov, S., Chen, Z., & Tokay, T. (2016) · Oncology Letters · doi:10.3892/ol.2016.4636 · Cited by 53
Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation Treatment
Radpour, R., Barekati, Z., Kohler, C., Schumacher, M. M., Grussenmeyer, T., Jenoe, P., Hartmann, N., Moes, S., Letzkus, M., Bitzer, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027355 · Cited by 52
Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer
LI, D.-C., Zhang, Y., Xie, Y., Xiang, J., Zhu, Y., & Yang, J. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.14 · Cited by 52
Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy
Li, Z., Ren, J., Li, H., Zhao Lu, K. O. N. G., & Zhu, H. (2004) · Cell Research · doi:10.1038/sj.cr.7290253 · Cited by 52
Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection
Hu, T., Wang, C., Huang, C., Chen, C., Hung, C., Chen, C., Wang, J., Lu, S., Lee, C., Changchien, C., et al. (2007) · Oncology Reports · doi:10.3892/or.18.6.1417 · Cited by 51
p53 Down-Regulates Phosphatase and Tensin Homologue Deleted on Chromosome 10 Protein Stability Partially through Caspase-Mediated Degradation in Cells with Proteasome Dysfunction
Tang, Y., & Eng, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0772 · Cited by 50
Anti‐leukaemic effects induced by APR‐246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells
Ali, D., Mohammad, D. K., Mujahed, H., Jonson‐Videsäter, K., Nore, B., Paul, C., & Lehmann, S. (2016) · British Journal of Haematology · doi:10.1111/bjh.14036 · Cited by 49
Regulation of the tumor suppressor PTEN by natural anticancer compounds
Kim, D., Suh, J., Surh, Y., & Na, H. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13422 · Cited by 48
Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway
Sun, Y., Tian, H., & Wang, L. (2015) · Oncology Reports · doi:10.3892/or.2015.3804 · Cited by 48
Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization
Gama, V, Gomez, J. A., Mayo, L. D., Jackson, M. W., Danielpour, D., Song, K., Haas, A. L., Laughlin, M. J., & Matsuyama, S. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.6 · Cited by 46
Self-citation
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
Barekati, Z., Radpour, R., Kohler, C., Zhang, B., Toniolo, P. G., Lenner, P., Lv, Q., Zheng, H. Y., & Zhong, X. Y. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq199 · Cited by 46
A novel site of AKT‐mediated phosphorylation in the human MDM2 onco‐protein
Milne, D., Kampanis, P., Nicol, S. M., Dias, S. S., Campbell, D. G., Fuller-Pace, F. V., & Meek, D. W. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.081 · Cited by 46
MicroRNA as potential modulators in chemoresistant high-grade gliomas
Low, S. Y. Y., Ho, Y. K., Too, H., Yap, C. T., & Ng, W. H. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.07.033 · Cited by 45
Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK
Wolf, E. R., McAtarsney, C. P., Bredhold, K. E., Kline, A. M., & Mayo, L. D. (2018) · Science Signaling · doi:10.1126/scisignal.aao4170 · Cited by 44
Self-citation
Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
Jacob, A., Oblinger, J. L., Bush, M. L., Brendel, V. J., Santarelli, G. D., Chaudhury, A. R., Kulp, S. K., Perle, K. M. D. L., Chen, C., Chang, L., et al. (2011) · The Laryngoscope · doi:10.1002/lary.22392 · Cited by 43
Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells
Yi, H., Kim, S., Hwang, P., Kim, C. Y., Yang, D.-H., Oh, Y., & Lee, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.045 · Cited by 44
Cowden's disease: clinical and molecular genetic findings in a patient with a novelPTENgermline mutation
REIFENBERGER, J., Rauch, L., Beckmann, M. W., Megahed, M., Ruzicka, T., & Reifenberger, G. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05322.x · Cited by 44
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171207 · Cited by 43
Genetic interactions between Pten and p53 in radiation-induced lymphoma development
Mao, J., Wu, D., Pérez‐Losada, J., Nagase, H., Delrosario, R., & Balmain, A. (2003) · Oncogene · doi:10.1038/sj.onc.1207083 · Cited by 43
The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
Ying, M., Zhang, L., Zhou, Q., Shao, X., Cao, J., Zhang, N., Li, W., Zhu, H., Yang, B., & He, Q. (2016) · Oncogene · doi:10.1038/onc.2015.503 · Cited by 41
Mutation matters in precision medicine: A future to believe in
Dey, N., Williams, C. B., Leyland-Jones, B. R., & De, P. K. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.002 · Cited by 41
The nuclear phosphoinositide response to stress
Chen, M., Wen, T., Horn, H. T., Chandrahas, V. K., Thapa, N., Choi, S., Cryns, V. L., & Anderson, R. A. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1711316 · Cited by 39
Inhibition of phosphatidylinositol 3‐kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells
Klingler‐Hoffmann, M., Bukczynska, P. E., & Tiganis, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.11085 · Cited by 41
Association of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinoma
Ma, J., Zhang, J., Ning, T., Chen, Z., & Xu, C. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.15 · Cited by 40
Sulforaphane-induced apoptosis involves p53 and p38 in melanoma cells
Rudolf, K., Červinka, M., & Rudolf, E. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0959-7 · Cited by 40
MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas
Wang, Y., Wang, X., Zhang, J., Sun, G., Luo, H., Kang, C., Pu, P., Jiang, T., Liu, N., & You, Y. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0679-1 · Cited by 39
Tp53 and its potential therapeutic role as a target in bladder cancer
Ciccarese, C., Massari, F., Blanca, A., Tortora, G., Montironi, R., Liang Cheng, C., Scarpelli, M., Raspollini, M. R., Vau, N., Fonseca, J., et al. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1297798 · Cited by 39
Combination of Biochanin A and Temozolomide Impairs Tumor Growth by Modulating Cell Metabolism in Glioblastoma Multiforme
Desai, V. S., Jain, A., Shaghaghi, H., Summer, R. S., LAI, J. C. K., & Bhushan, A. (2018) · Anticancer Research · doi:10.21873/anticanres.13079 · Cited by 38
Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer
Couto, S. S., Cao, M., Duarte, P. C. X., Banach-Petrosky, W. A., Wang, S., Romanienko, P. J., Wu, H., Cardiff, R. D., Abate-Shen, C. T., & Cunha, G. R. (2009) · Differentiation · doi:10.1016/j.diff.2008.09.010 · Cited by 38
ΔNp73α inhibits PTEN expression in thyroid cancer cells
Vella, V., Puppin, C., Damante, G., Vigneri, R., Sanfilippo, M., Vigneri, P. G., Tell, G., & Frasca, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.24221 · Cited by 37
Therapeutic potential of phosphoinositide 3-kinase inhibitors
Drees, B. E., Mills, G. B., Rommel, C., & Prestwich, G. D. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.5.703 · Cited by 37
GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development
Song, H., Sun, B., Liao, Y., Xu, D., Guo, W., Wang, T., Jing, B., Hu, M., Li, K., Yao, F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31726 · Cited by 35
Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer
Li, W., Peng, X., Lang, J., & Xu, C. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00631 · Cited by 36
Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53
Wiedemuth, R., Klink, B., Töpfer, K., Schröck, E., Schackert, G., Tatsuka, M., & Temme, A. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-107 · Cited by 36
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 38
Cell cycle arrest induced by engagement of B7‐H4 on Epstein–Barr virus‐positive B‐cell lymphoma cell lines
Park, G. B., Song, H., Kim, Y. S., Sung, M., Ryu, J. W., Lee, H., Cho, D., Kim, D., Lee, W. J., & Hur, D. Y. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03111.x · Cited by 34
Expression of p53 and PTEN in human primary endometrial carcinomas: Clinicopathological and immunohistochemical analysis and study of their concomitant expression
Stavropoulos, A., Varras, M. N., Vasilakaki, T., Varra, V., Tsavari, A., Varra, F., Nonni, A., Kavantzas, N., & Lazaris, A. C. (2019) · Oncology Letters · doi:10.3892/ol.2019.10093 · Cited by 35
Tumor p53 status and response to topoisomerase II inhibitors
Valkov, N. I., & Sullivan, D. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00143-7 · Cited by 35
The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck
Rogers, S. J., Box, C., Harrington, K. J., Nutting, C. M., Rhys‐Evans, P. H., & Eccles, S. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.769 · Cited by 34
Adenovirus-Mediated PTEN Treatment Combined with Caffeine Produces a Synergistic Therapeutic Effect in Colorectal Cancer Cells
Saito, Y., Gopalan, B., Mhashilkar, A. M., Roth, J. A., Chada, S., Zumstein, L., & Ramesh, R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700644 · Cited by 33
Caffeine Confers Radiosensitization of PTEN-Deficient Malignant Glioma Cells by Enhancing Ionizing Radiation–Induced G1 Arrest and Negatively Regulating Akt Phosphorylation
Sinn, B., Tallen, G. R. N., Schroeder, G., Grassl, B., Schulze, J., Budach, V., & Tinhofer, I. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0498 · Cited by 33
FGFR and PTEN signaling interact during lens development to regulate cell survival
Chaffee, B. R., Hoang, T. V., Leonard, M. R., Bruney, D. G., Wagner, B. D., Dowd, J. R., Leone, G. W., Ostrowski, M. C., & Robinson, M. L. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2015.12.027 · Cited by 33
The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma
Sioletic, S., & Scambia, G. (2019) · Cancers · doi:10.3390/cancers11081169 · Cited by 32
Crosstalk between kinases and Nedd4 family ubiquitin ligases
An, H., Krist, D. T., & Statsyuk, A. V. (2014) · Molecular BioSystems · doi:10.1039/c3mb70572b · Cited by 32
Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3Kα inhibition
Fan, Y., Ding, H., Liu, D., Song, H., Xu, Y., & Wang, J. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.02.015 · Cited by 31
Long noncoding RNA HOTAIR interacts with Y-Box Protein-1 (YBX1) to regulate cell proliferation
Li, S., Xiong, Q., Chen, M., Wang, B., Yang, X. F., Yang, M., Wang, Q., Cui, Z., & Ge, F. (2021) · Life Science Alliance · doi:10.26508/lsa.202101139 · Cited by 32
Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
Wu, D., Lu, P., Mi, X., & Miao, J. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4649-0 · Cited by 30
microRNAs and Esophageal Cancer - Implications for Pathogenesis and Therapy
Mayne, G. C., Hussey, D. J., & Watson, D. I. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804805702 · Cited by 29
Propofol Prevents Hippocampal Neuronal Loss and Memory Impairment in Cerebral Ischemia Injury Through Promoting PTEN Degradation
Chen, X., Du, Y., Xu, F., Liu, D., & Wang, Y.-L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0791-y · Cited by 29
Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network
Inoue, K., & Fry, E. A. (2018) · Cancer Investigation · doi:10.1080/07357907.2018.1533965 · Cited by 27
Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells
Naderali, E., Valipour, B., Khaki, A. A., Rad, J. S., Alihemmati, A., Rahmati, M., & Charoudeh, H. N. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.056 · Cited by 29
The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies
Maksoud, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02915-2 · Cited by 29
Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after γ-irradiation
Ohi, H., Mishima, Y., Kamimura, K., Maruyama, M., Sasai, K., & Kominami, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210325 · Cited by 28
Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide
Tao, W., Hangoc, G., Hawes, J. W., Si, Y. C., Cooper, S. H., & Broxmeyer, H. E. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(02)01083-4 · Cited by 29
The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms
de Assis, L. V. M., & Isoldi, M. C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1210-4 · Cited by 27
RETRACTED: Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF‐7 breast cancer cells
Panno, M., Giordano, F., Mastroianni, F., Morelli, C., Brunelli, E., Palma, M. G., PELLEGRINO, M. A., Aquila, S., Miglietta, A., Mauro, L., et al. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.055 · Cited by 28
Retracted
Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest
Qian (2009) · Oncology Reports · doi:10.3892/or_00000483 · Cited by 28
Genetic Modeling of Glioma Formation in Mice
Begemann, M., Fuller, G. N., & Holland, E. C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00428.x · Cited by 28
Exposure to dibutyl phthalate adsorbed to multi-walled carbon nanotubes causes neurotoxicity in mice by inducing the release of BDNF
Zhou, T., He, S., Ye, X., Wei, Z., Wan, J., Zhang, H., & Ding, S. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158319 · Cited by 27
Induction of Apoptotic Genes by a p73-Phosphatase and Tensin Homolog (p73-PTEN) Protein Complex in Response to Genotoxic Stress
Lehman, J. A., Waning, D. L., Batuello, C. N., Cipriano, R., Kadakia, M., & Mayo, L. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217620 · Cited by 27
Self-citation
Control of Phosphatase and Tensin Homolog (PTEN) Gene Expression in Normal and Neoplastic Thyroid Cells
Tell, G., Pines, A., Arturi, F., Cesaratto, L., Adamson, E. D., Puppin, C., Presta, I., Russo, D., Filetti, S., & Damante, G. (2004) · Endocrinology · doi:10.1210/en.2004-0282 · Cited by 27
Regulation of the DNA Damage Response by p53 Cofactors
Zhang, X. P., Liu, F., & Wang, W. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.002 · Cited by 25
When PIP2 Meets p53: Nuclear Phosphoinositide Signaling in the DNA Damage Response
Wang, Y., & Sheetz, M. P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.903994 · Cited by 25
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo
De, P. K. R., Dey, N., Terakedis, B. E., Bergsagel, P. L., Li, Z. H., Mahadevan, D., Garlich, J. R., Trudel, S., Makale, M., & Durden, D. L. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2078-0 · Cited by 25
Self-citation
A role for the p53 pathway in the pathology of meningiomas with NF2 loss
Chang, Z., Guo, C., Ahronowitz, I. Z., Stemmer-Rachamimov, A. O., MacCollin, M., & Nunes, F. P. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9721-3 · Cited by 25
Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displayingin vitroefficacy against melanoma cells
Capasso, A., Cerchia, C., Giovanni, C. D., Granato, G., Albano, F., Romano, S., Vendittis, E. D., Ruocco, M. R., & Lavecchia, A. (2015) · Oncotarget · doi:10.18632/oncotarget.5473 · Cited by 24
Oral tumors in children: Diagnosis and management
Khanmohammadi, R., Mir, F., Baniebrahimi, G., & Mirzaei, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26316 · Cited by 24
Epithelial cell cycling predicts p53 responsiveness to γ-irradiation during post-natal mammary gland development
Minter, L. M., Dickinson, E. S., Naber, S. P., & Jerry, D. J. (2002) · Development · doi:10.1242/dev.129.12.2997 · Cited by 20
Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits
Mitra, A., Jia, G.-H., Gangahar, D. M., & Agrawal, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00311.x · Cited by 25
p16 INK 4a deficiency promotes DNA hyper‐replication and genetic instability in melanocytes
Fung, C., Pupo, G. M., Scolyer, R. A., Kefford, R. F., & Rizos, H. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12062 · Cited by 23
Genomic aberrations of MDM 2, MDM 4, FGFR 1 and FGFR 3 are associated with poor outcome in patients with salivary gland cancer
Ach, T., Schwarz‐Furlan, S., Ach, S., Agaimy, A., Gerken, M., Rohrmeier, C., Zenk, J., Iro, H., Brockhoff, G., & Ettl, T. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12394 · Cited by 22
Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer
Gâtel, P., Piechaczyk, M., & Bossis, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_2 · Cited by 23
Dynamic interplay between autophagic flux and A kt during melanoma progression in vitro
Maes, H., Martín-Acebes, M. A., Verfaillie, T., & Agostinis, P. (2013) · Experimental Dermatology · doi:10.1111/exd.12298 · Cited by 21
Qualitative Network Modeling of the Myc-p53 Control System of Cell Proliferation and Differentiation
Aguda, B. D., Kim, Y., Kim, H. S., Friedman, A., & Fine, H. A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.09.052 · Cited by 21

Authors: Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., & Donner, D. B.
Affiliations: Indiana University Indianapolis (US)
University of Michigan (US)
Indiana University School of Medicine (US)
Corresponding author: Donner, David B.
ORCID: Mayo, Lindsey D.
Dixon, Jack E.
Durden, Donald L.
Donner, David B.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2002-02
Volume: 277
Issue: 7
Pages: 5484-5489
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m108302200
OpenAlex: W2132279561
Cited by: 351
References: 64
Citations by year: 2026: 3 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 14 · 2020: 8 · 2019: 8 · 2018: 17 · 2017: 19 · 2016: 11 · 2015: 13 · 2014: 18 · 2013: 15 · 2012: 11
FWCI: 11.68
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 6901 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
Keywords: PTEN, p53, MDM2, tumor suppressor cooperation, glioblastoma, etoposide sensitivity, chemosensitization, PI3K/Akt signaling, nuclear translocation, cell cycle arrest, positive feedback loop, DNA damage response, U87 cells
MeSH terms: Cell Cycle, Cell Line, Cell Nucleus, Cloning, Molecular, Cytoplasm, DNA Damage, Dose-Response Relationship, Drug, Coloring Agents, Etoposide, Glioblastoma, Humans, Mutation, Neoplasms, Nuclear Proteins, Phosphoric Monoester Hydrolases, Precipitin Tests, Proto-Oncogene Proteins, Retroviridae, Tetrazolium Salts, Thiazoles, Transcription, Genetic, Transduction, Genetic, Tumor Cells, Cultured, Blotting, Western, Signal Transduction, Down-Regulation, Tumor Suppressor Protein p53, Genes, Reporter, Microscopy, Confocal, Tumor Suppressor Proteins, PTEN Phosphohydrolase, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks